Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colette B Raymond

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
CANNT Journal = Journal ACITN|November 11, 2009
Reduced drug costs from switching hemodialysis patients from epoetin alfa in multidose vials to pre-filled syringesLori D Wazny, Colette B Raymond, Michelle K Do, et al.
The Canadian Journal of Hospital Pharmacy|April 6, 2012
Organizational restructuring of regional pharmacy services to enable a new pharmacy practice modelKevin W Hall, Colette B Raymond, Donna M M Woloschuk, et al.
CANNT Journal = Journal ACITN|August 2, 2008
Are CSN and NKF-K/DOQI mineral metabolism guidelines for hemodialysis patients achievable? Results from a provincial renal programLori D Wazny, Colette B Raymond, Esther M Lesperance, et al.
American Journal of Nephrology|December 17, 2013
Cost analysis of an intravenous to subcutaneous epoetin α conversionLori D Wazny, Colette B Raymond, Amy R Sood, et al.
The Canadian Journal of Hospital Pharmacy|July 12, 2012
Development and implementation of a regional program for the safe handling of hazardous drugs by hospital pharmaciesBarbara Sproll, Heather Milan, Cenzina Caligiuri, et al.
CANNT Journal = Journal ACITN|July 21, 2010
Treatment of restless legs syndrome in patients with chronic kidney disease: a focus on medicationsColette B Raymond, Lance Breland, Lori D Wazny, et al.
Nephron. Clinical Practice|November 12, 2005
Erythropoietin-alpha dosage requirements in a provincial hemodialysis population: effect of switching from subcutaneous to intravenous administrationColette B Raymond, David M Collins, Keevin N Bernstein, et al.
CMAJ Open|June 29, 2017
Opioid use during pregnancy: a population-based cohort studyJamie Falk, Matthew Dahl, Colette B Raymond, et al.
CANNT Journal = Journal ACITN|April 26, 2008
Conversion from epoetin alfa to darbepoetin alfa within the Manitoba Renal Program: evaluation of dose ratiosColette B Raymond, Lori D Wazny, Lavern M Vercaigne, et al.
Implementation Science : IS|November 28, 2017
The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysisHeather C Worthington, Lucy Cheng, Sumit R Majumdar, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
CANNT Journal = Journal ACITN|November 11, 2009
Reduced drug costs from switching hemodialysis patients from epoetin alfa in multidose vials to pre-filled syringesLori D Wazny, Colette B Raymond, Michelle K Do, et al.
The Canadian Journal of Hospital Pharmacy|April 6, 2012
Organizational restructuring of regional pharmacy services to enable a new pharmacy practice modelKevin W Hall, Colette B Raymond, Donna M M Woloschuk, et al.
CANNT Journal = Journal ACITN|August 2, 2008
Are CSN and NKF-K/DOQI mineral metabolism guidelines for hemodialysis patients achievable? Results from a provincial renal programLori D Wazny, Colette B Raymond, Esther M Lesperance, et al.
American Journal of Nephrology|December 17, 2013
Cost analysis of an intravenous to subcutaneous epoetin α conversionLori D Wazny, Colette B Raymond, Amy R Sood, et al.
The Canadian Journal of Hospital Pharmacy|July 12, 2012
Development and implementation of a regional program for the safe handling of hazardous drugs by hospital pharmaciesBarbara Sproll, Heather Milan, Cenzina Caligiuri, et al.
CANNT Journal = Journal ACITN|July 21, 2010
Treatment of restless legs syndrome in patients with chronic kidney disease: a focus on medicationsColette B Raymond, Lance Breland, Lori D Wazny, et al.
Nephron. Clinical Practice|November 12, 2005
Erythropoietin-alpha dosage requirements in a provincial hemodialysis population: effect of switching from subcutaneous to intravenous administrationColette B Raymond, David M Collins, Keevin N Bernstein, et al.
CMAJ Open|June 29, 2017
Opioid use during pregnancy: a population-based cohort studyJamie Falk, Matthew Dahl, Colette B Raymond, et al.
CANNT Journal = Journal ACITN|April 26, 2008
Conversion from epoetin alfa to darbepoetin alfa within the Manitoba Renal Program: evaluation of dose ratiosColette B Raymond, Lori D Wazny, Lavern M Vercaigne, et al.
Implementation Science : IS|November 28, 2017
The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysisHeather C Worthington, Lucy Cheng, Sumit R Majumdar, et al.
Pageof 5